TLR4 and cancer: Further mechanistic insights have been gained from examining skeletal muscle atrophy in cancer cachexia, where it has been reported that cancer cells activate Toll-like receptor 4 in skeletal muscle, which then phosphorylates CBP/p300 via the p38β–MAPK pathway [181].